Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in ....Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Read moreRead less
A comparative study of the distribution and spread of potential molecular markers for Mundulla Yellows disease. Mundulla Yellows (MY), a newly recognised widespread lethal disease of Eucalyptus spp.in Australia, is a serious threat to national biodiversity and conservation. It is contagious, apparently biotic, but the causal agent is unknown. Identification of the cause is essential to establish sustainable control measures. We have detected a range of MY-associated RNAs constituting a disease ' ....A comparative study of the distribution and spread of potential molecular markers for Mundulla Yellows disease. Mundulla Yellows (MY), a newly recognised widespread lethal disease of Eucalyptus spp.in Australia, is a serious threat to national biodiversity and conservation. It is contagious, apparently biotic, but the causal agent is unknown. Identification of the cause is essential to establish sustainable control measures. We have detected a range of MY-associated RNAs constituting a disease 'fingerprint'. To identify individual RNAs uniquely associated with MY we aim to compare MY-RNA fingerprints from a range of affected species from different sites and with varying symptoms. Candidate RNAs will be cloned both for establishing molecular diagnostics for MY and identifying the cause.Read moreRead less